广州医药 ›› 2016, Vol. 47 ›› Issue (4): 21-24.DOI: 10.3969/j.issn.1000-8535.2016.04.006

• 论著 • 上一篇    下一篇

胰腺神经鞘瘤临床诊治分析

李宁, 翁杰锋, 张强, 林帆, 朱光辉, 温敏杰, 古维立   

  1. 广州医科大学附属广州市第一人民医院肝胆外科, 广州消化疾病中心(广州 510180)
  • 收稿日期:2016-04-07 出版日期:2016-07-20 发布日期:2021-12-02
  • 通讯作者: 古维立,E-mail: guwl1955@126.com
  • 基金资助:
    国家自然科学基金项目(81400679);广东省基础与应用基础研究专项资金项目(2014A030310067);广东省医学科研基金项目(B2014340)

Clinical analysis of diagnosis and treatment of pancreatic schwannoma

Li Ning, Weng Jiefeng, Zhang Qiang, et al   

  1. Department of Hepatobiliary Surgery, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, China
  • Received:2016-04-07 Online:2016-07-20 Published:2021-12-02

摘要: 目的 探讨胰腺神经鞘瘤的临床特点和诊治方法。方法 总结并回顾性分析我院肝胆外科收治的胰腺神经鞘瘤患者1例及文献报道的71例患者临床资料。结果 共计72例胰腺神经鞘瘤患者纳入总结和分析。患者平均年龄54岁(范围17~89岁),其中女性40例(56%)。临床表现包括上腹痛、体重减轻,或体检偶然发现胰腺肿物。肿瘤平均大小6.1 cm(1~20 cm)。肿瘤位于胰头部29例(40%)、胰体/尾部32例(44%),沟突部6例(8%)。肿瘤表现为实性肿物27例(38%)、囊性28例(39%)、囊实性10例(14%)。2例通过术前超声内镜下穿刺活检病理确诊,其余均为手术后标本病理诊断证实。手术治疗行胰十二指肠切除术23例、局部剜除术16例、胰体尾切除术15例、胰腺中段切除1例。5例 (7%) 患者术后病理为恶性神经鞘瘤,恶性组肿瘤大小明显大于良性组[(13.8±6.2)cm vs (5.6±4.1)cm,P=0.0004)]。手术切除患者术后随访3~65月,均无肿瘤复发、转移及患者死亡。结论 胰腺神经鞘瘤临床表现缺少特异性,术前诊断困难,肿瘤大小与良恶性具有明显相关性,手术治疗可取得良好效果。

关键词: 胰腺神经鞘瘤, 诊断, 治疗

Abstract: Objective To analyze clinical presentation, diagnosis, treatment options, and outcome of pancreatic schwannoma. Methods A retrospective study of clinical data of a case in our hospital and 71 cases reported in literature with pancreatic schwannoma. Results 72 cases were analysed. The mean age was 54 years (range 17-89 years), with 56 % of patients being female. Mean tumor size was 6.1 cm (range 1-20 cm). Tumor location was the head (29 cases), body and tail (32 cases), and uncinate process (6 cases). 27 cases exhibited solid tumors and 28 cases exhibited cystic tumors. Treatment included pancreaticoduodenectomy (23 cases), distal pancreatectomy (15 cases), enucleation (16 cases). 5 cases (7%) were malignant schwannoma. Tumor size of malignant group was significant larger than benign group (13.8±6.2 cm vs 5.6±4.1 cm,P=0.0004). There was no local recurrence metastasis,or death at the follow-up after operation (range 3-65 months). Conclusion The clinical manifestations of pancreatic schwannoma are lack of specificity and preoperative diagnosis remains difficulty. The tumor size was significantly related to classification of malignant or benign. Pancreatic schwannoma has satisfactory prognosis with surgical treatment.

Key words: Pancreatic schwannoma, Diagnosis, Treatment